| Galderma SA - Mirvaso 3.3mg/g, Gel |
| 65180 | | 01 | | Mirvaso 3.3mg/g | | Gel | | D11AX21 | | Brimonidine | | 21.11.2014 | | |
|
| Composition |
| brimonidinum 3.3 mg ut brimonidini tartras, propylenglycolum, conserv.: phenoxyethanolum, E 218, excipiens ad gelatum. |
| Packungsbestandteile |
| Gel | | | | | | | | Active Agent | Dose |
|---|
| Brimonidine | 3.3 mg correspond Brimonidine Tartrate |
| | BAG: Active Agent | Dose |
|---|
| Brimonidine | 3.3 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 218 | | conserv. | | Phenoxyethanol | | conserv. | | Propylenglycol | | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 g | 37.44 | 57.15 | B | SL | Yes |
|
